» Authors » Kiyoko Tamai

Kiyoko Tamai

Explore the profile of Kiyoko Tamai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 284
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakashima N, Jin W, Wachino J, Koyama S, Tamai K, Arakawa Y, et al.
Jpn J Infect Dis . 2024 Jan; 77(4):236-239. PMID: 38296542
All clinical isolates of Streptococcus dysgalactiae subsp. equisimilis (SDSE) are considered susceptible to β-lactams, the first-line drugs used to treat SDSE infections. However, given that penicillin-non-susceptible SDSE strains have been...
2.
Nakano E, Koyama S, Imai M, Machida Y, Sakanoue T, Nakahara T, et al.
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi . 2022 Dec; 32(1):1-11. PMID: 36560902
We compared rapid antigen detection kits widely used for the rapid diagnosis of group A streptococcal pharyngitis, evaluating their minimum detection sensitivity and operability in five levels. Five kits based...
3.
Yamaguchi T, Nakamura I, Sato T, Ono D, Sato A, Sonoda S, et al.
Microbiol Spectr . 2022 Jun; 10(4):e0227221. PMID: 35758725
Although community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged worldwide, no nationwide CA-MRSA surveillance has been conducted in Japan to determine the changes in its molecular characteristics over time. We aimed...
4.
Sarangi J, Matsuo N, Nonogaki R, Hayashi M, Kawamura K, Suzuki M, et al.
Jpn J Infect Dis . 2021 Jul; 75(1):41-48. PMID: 34193664
The Enterobacter cloacae complex (ECC) is one of the most common causes of bacteremia and leads to poor clinical outcomes. The aim of this study was to clarify the antimicrobial...
5.
Kosai K, Suzuki H, Tamai K, Okada Y, Akamatsu N, Ueda A, et al.
Sci Rep . 2021 Feb; 11(1):3033. PMID: 33542335
We investigated the efficiency of the Verigene Enteric Pathogens Nucleic Acid Test (Verigene EP test), which is an automated microarray-based assay system that enables rapid and simultaneous genetic detection of...
6.
Shirata M, Yoshimoto Y, Marumo S, Tamai K, Fukui M
Int J Infect Dis . 2020 Jun; 97:270-277. PMID: 32526389
Objectives: A standard treatment regimen against Mycobacteroides abscessus complex (MABC) infections has not yet been established, making MABC difficult to treat successfully. In this study, we sought to develop an...
7.
Hara T, Suzuki H, Oyanagi T, Koyanagi N, Ushiki A, Kawabata N, et al.
PLoS One . 2020 Jun; 15(6):e0234119. PMID: 32492051
Recently, a new rapid assay for the detection of tcdB gene of Clostridioides difficile was developed using the GENECUBE. The assay can directly detect the tcdB gene from stool samples...
8.
Hashimoto Y, Taniguchi M, Uesaka K, Nomura T, Hirakawa H, Tanimoto K, et al.
Front Microbiol . 2019 Dec; 10:2568. PMID: 31798546
Vancomycin-resistant enterococci are troublesome pathogens in clinical settings because of few treatment options. A VanA/VanM-type vancomycin-resistant clinical isolate was identified in Japan. This strain, named AA708, harbored five plasmids, one...
9.
Taniguchi Y, Koide S, Maeyama Y, Tamai K, Hayashi W, Tanaka H, et al.
J Glob Antimicrob Resist . 2019 Sep; 20:253-259. PMID: 31472282
Objectives: To characterise the genotypic profiles of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from companion animals and to investigate their association with those from humans in Japan. Methods: Non-duplicated MRSA...
10.
Hashimoto Y, Kurushima J, Nomura T, Tanimoto K, Tamai K, Yanagisawa H, et al.
BMC Microbiol . 2018 Dec; 18(1):213. PMID: 30545294
Background: VanB-type vancomycin (VAN) resistance gene clusters confer VAN resistances on Enterococcus spp. over a wide range of MIC levels (MIC = 4-1000 mg/L). However, the epidemiology and the molecular...